19 completed, 4 recruiting, 3 unknown, 1 active not recruiting. 29 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 29 | Completed 19, Recruiting 4, Unknown 3, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1 |
Follow Eczema: new trials by email Literature Review of Eczema trials Research Report on Eczema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact of Dietary Salt on the Severity of Eczema Sodium chloride tablets, Placebo Tablets - Eczema, Atopic Dermatitis | Phase 4 | Recruiting | University of California, San Francisco | 40 | 2026-08-10 | 2026-09-10 |
| Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream. Roflumilast Cream 0.15% - ITCH, Atopic Dermatitis | Phase 4 | Recruiting | Integrative Skin Science and Research | 40 | 2026-07-21 | 2026-08-13 |
| The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease Sodium chloride tablets, Placebo Tablets - Atopic Dermatitis (Eczema), Psoriasis | Phase 4 | Recruiting | University of California, San Francisco | 50 | 2026-07-14 | 2026-09-09 |
| Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis Application of crisaborole twice daily, Tacrolimus ointment in atopic dermatitis - Dermatitis, Atopic, Eczema | Phase 4 | Not yet recruiting | Cairo University | 30 | 2026-02-01 | 2026-01-26 |
| Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With Dupilumab dupilumab - Severe Atopic Dermatitis (AD) | Phase 4 | Withdrawn | Regeneron Pharmaceuticals | 2025-11-11 | 2025-11-28 | |
| Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children Measles-Mumps-Rubella vaccine (MMR) - Respiratory Tract Infections, Infections | Phase 4 | Recruiting | Laure Pittet, MD-PhD | 500 | 2023-03-17 | 2024-05-29 |
| Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab Abrocitinib - Atopic Dermatitis | Phase 4 | Completed | Innovaderm Research Inc. | 24 | 2022-11-25 | 2025-03-28 |
| Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging. Dupilumab, Optical Coherence Tomography, Reflectance confocal microscopy - Eczema, Atopic Dermatitis | Phase 4 | Unknown | OptiSkin Medical | 15 | 2022-03-01 | 2022-03-03 |
| The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment Dupilumab Prefilled Syringe - Atopic Dermatitis, Eczema | Phase 4 | Completed | Jonathan A. Bernstein, MD | 12 | 2020-09-01 | 2023-02-08 |
| An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis Dupilumab Only Product - Atopic Dermatitis, AD | Phase 4 | Unknown | Eric Simpson | 45 | 2020-09-01 | 2020-08-20 |
| Steroid-reducing Effects of Crisaborole Crisaborole, Hydrocortisone Ointment, Triamcinolone ointment - Atopic Dermatitis, Eczema | Phase 4 | Completed | Johns Hopkins University | 24 | 2019-12-17 | 2024-07-19 |
| Response of Children With Atopic Dermatitis (Eczema) to Eucrisa Crisaborole - Atopic Dermatitis, Eczema | Phase 4 | Completed | Ann & Robert H Lurie Children's Hospital of Chicago | 30 | 2019-10-03 | 2022-07-19 |
| The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients Dupilumab - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 4 | Completed | University of California, San Francisco | 34 | 2018-11-01 | 2024-01-09 |
| Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis Dupilumab - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 4 | Completed | University of California, San Francisco | 17 | 2018-10-22 | 2025-11-14 |
| Effect of Sublingual Immunotherapy in Patients With Atopic Dermatitis Mite extract sublingual immunotherapy (SLIT), Placebo - Atopic Dermatitis, Effects of Immunotherapy | Phase 4 | Completed | Casa Espirita Terra de Ismael | 91 | 2018-05-02 | 2020-08-26 |
| Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis Investigational OTC Cream, Cosmetic Eczema Cream, 0.05% Desonide Cream - Dermatitis, Atopic, Eczema | Phase 4 | Completed | Procter & Gamble Beauty | 53 | 2016-03-01 | 2016-10-05 |
| Can Vitamin D Supplementation in the First Year of Life Prevent Food Allergy in Infants? The VITALITY Trial: Parts 1&2 Vitamin D, placebo - Food Allergy | Phase 4 | Active not recruiting | Murdoch Childrens Research Institute | 2739 | 2014-12-01 | 2025-12-03 |
| The Randomized Controlled Clinical Trial of Kushen Injection Compound Kushen Injection - Lung Cancer | Phase 4 | Unknown | Beijing Zheng Ju Medical Technology Co., Ltd. | 240 | 2014-11-01 | 2017-07-21 |
| Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection Retapamulin (Altabax) - Impetigo, Folliculitis | Phase 4 | Completed | The University of Texas Health Science Center, Houston | 38 | 2010-04-01 | 2016-02-17 |
| Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis Elidel (pimecrolimus cream, 1%) Hylatopic Plus Emollient Foam (non-medicated device) - Eczema, Atopic Dermatitis | Phase 4 | Completed | Frankel, Amylynne, M.D. | 30 | 2010-03-01 | 2011-04-15 |
Showing 20 of 29. Sign in to see all of them.
Dermatitis, Atopic (25) · Dermatitis (4) · Pruritus (3) · Infections (2) · Folliculitis (1) · Food Hypersensitivity (1) · Hypersensitivity (1) · Impetigo (1) · Lung Neoplasms (1) · Psoriasis (1) · Respiratory Tract Infections (1)
Skin Diseases (29) · Skin Diseases, Eczematous (29) · Skin and Connective Tissue Diseases (29) · Immune System Diseases (27) · Hypersensitivity (26) · Hypersensitivity, Immediate (26) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (25) · Dermatitis (25) · Genetic Diseases, Inborn (25) · Skin Diseases, Genetic (25) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Skin Manifestations (3) · Respiratory Tract Diseases (2) · Bacterial Infections (1)
dupilumab (6) · pimecrolimus (3) · Sodium Chloride (2) · crisaborole (2) · Cholecalciferol (1) · Fluocinonide (1) · Measles-Mumps-Rubella Vaccine (1) · Petrolatum (1) · Sublingual Immunotherapy (1) · Tomography, Optical Coherence (1) · Vitamin D (1) · abrocitinib (1) · montelukast (1) · retapamulin (1)
University of California, San Francisco (4) · Ceragenix Pharmaceuticals (2) · Novartis (2) · 1st Allergy & Clinical Research Center (1) · Ann & Robert H Lurie Children's Hospital of Chicago (1) · Bayer (1) · Beijing Zheng Ju Medical Technology Co., Ltd. (1) · Cairo University (1) · Casa Espirita Terra de Ismael (1) · Eric Simpson (1) · Frankel, Amylynne, M.D. (1) · Innovaderm Research Inc. (1) · Integrative Skin Science and Research (1) · Johns Hopkins University (1) · Jonathan A. Bernstein, MD (1)
United States (17) · Germany (2) · Australia (1) · Brazil (1) · Canada (1) · China (1) · Philippines (1) · Spain (1) · Switzerland (1)
Katrina Abuabara, MD (2) · Adelaide A Hebert, M.D. (1) · Adnan Nasir, MD, PhD (1) · Anna Fishbein, MD (1) · Anna Grossberg, MD (1) · Eric Simpson, MD (1) · Eric Simspon, MD (1) · Isaac R Melamed, MD (1) · Jeffrey Sugarman, MD (1) · Jonathan Bernstein (1) · Karla L Arruda, PhD (1) · Kirsten Perrett, MD PhD (1) · Laure F Pittet, MD-PhD (1)